Cour Pharmaceuticals raises $30 million | Crain's Chicago Business

Cour Pharmaceuticals will use the money to develop therapies for conditions including celiac disease and peanut allergies.

Related Keywords

New York ,United States ,Chris Dimitropoulos ,Cour Pharmaceuticals ,Alpha Wave Ventures ,Alpha Wave ,